1-6 of 6
Guner Hayri Ozsan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment with Daratumumab Plus Bortezomib, Cyclophosphamide, and Dexamethasone May Result in Both Hematologic and Metabolic Complete Response to Achieve Long-Term Progression Free Survival Among Patients Presenting with Extra-Medullary Disease: A European Myeloma Network Study (EMN19)

Meral Beksac, Tulin Tuglular, Francesca Gay, Roberto Mina, Eirini Katodritou, Ali Unal, Michele Cavo, Guner Hayri Ozsan, Vincent H.J. Van Der Velden, H. Berna Beverloo, Michael Vermeulen, Mark van Duin, Guldane Cengiz Seval, Omur Gokmen Sevindik, Serena Merante, Kyriaki Manousou, Pieter Sonneveld, Elena Zamagni, Evangelos Terpos
Journal: Blood
Blood (2023) 142 (Supplement 1): 1956.
https://doi.org/10.1182/blood-2023-178533
Published: 2023
Journal Articles

Efficacy of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting with Extramedullary Disease: A European Myeloma Network Study (EMN19)

Meral Beksac, Tulin Tuglular, Francesca Gay, Roberto Mina, Eirini Katodritou, Ali Unal, Michele Cavo, Guner Hayri Ozsan, Vincent H.J. van der Velden, Berna Beverloo, Michael Vermeulen, Mark van Duin, Guldane Cengiz, Omur Gokmen Sevindik, Serena Merante, Kyriaki Manousou, Pieter Sonneveld, Evangelos Terpos
Journal: Blood
Blood (2022) 140 (Supplement 1): 10177–10179.
https://doi.org/10.1182/blood-2022-160004
Published: 2022
Journal Articles

An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy

Omur Gokmen Sevindik, Zubeyde Nur Ozkurt, Can Boga, Sevgi Kalayoglu Besisik, Yildiz Ipek, Ayfer Geduk, Aybuke Harmandali, Ayse Salihoglu, Handan haydaroglu Sahin, Mehmet Sönmez, Filiz Vural, Olga Meltem Akay, Meltem Kurt Yuksel, Senem Maral, Omer Ekinci, Onur Hakki Kirkizlar, Atakan Tekinalp, Nazli Demir, Mustafa Merter, Guray Saydam, İnci Alacacıoğlu, Zeynep Arzu Yegin, Mutlu Kasar, Metban Mastanzade, Guner Hayri Ozsan
Journal: Blood
Blood (2021) 138 (Supplement 1): 4730.
https://doi.org/10.1182/blood-2021-150175
Published: 2021
Journal Articles

Safety of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Patients with Multiple Myeloma Presenting with Extramedullary Disease during the COVID-19 Pandemic

Meral Beksac, Tulin Tuglular, Ali Unal, Michele Cavo, Francesca Gay, Eirini Katodritou, Guner Hayri Ozsan, Guldane Cengiz, Omur Gokmen Sevindik, Serena Merante, Kyriaki Manousou, Pieter Sonneveld, Evangelos Terpos
Journal: Blood
Blood (2021) 138 (Supplement 1): 1657.
https://doi.org/10.1182/blood-2021-152444
Published: 2021
Journal Articles

Real-World Data in Relapsed Refractory Myeloma Patients Treated with Carfilzomib, a Multicenter Turkish Experience

Omur Gokmen Sevindik, MD, Mustafa Pehlivan, MD, Tulin F Tuglular, MD, Serife M Solmaz, MD, Mehmet Hilmi Dogu, Fevzi Yalniz, MD, Ali Ugur Ural, MD, Zafer Serenli Yeğen, MD, Mutlu Arat, MD, Vildan Ozkocaman, MD, Elif G Umit, MD, Handan Haydaroğlu Şahin, MD, Mehmet Sönmez, MD, Mehmet Turgut, MD, Muhit Ozcan, MD, Onder Arslan, MD, Yildiz Aydin, MD, Tayfun Elibol, MD, Aybuke Harmandali Olgun, MD, Banu Bayar, MD, Anil Tombak, MD, Ismet Aydogdu, MD, Güner Hayri Özsan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5405.
https://doi.org/10.1182/blood.V130.Suppl_1.5405.5405
Published: 2017
Journal Articles

Real-World Data in Relapsed Refractory Myeloma Patients Treated with Pomalidomide, a Multicenter Turkish Experience

Guner Hayri Ozsan, MD, Omur Gokmen Sevindik, MD, Sevil Sadri, MD, Sibel Kabukcu Hacioglu, MD, Sureyya Yigit Kaya, MD, Ayfer Geduk, MD, Ali Ugur Ural, MD, Tulin F Tuglular, MD, Vildan Ozkocaman, MD, Ahmet Muzaffer Demir, MD, Yildiz Aydin, MD, Gulsum Akgun Cagliyan, MD, Ismet Aydogdu, MD, Mustafa Pehlivan, MD, Ibrahim Muaz Yaradilmis, MD, Volkan Karakus, MD, Mehmet Yilmaz, MD, Meral Beksac, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5430.
https://doi.org/10.1182/blood.V130.Suppl_1.5430.5430
Published: 2017